| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5219940
Max Phase: Preclinical
Molecular Formula: C18H19N3O3S
Molecular Weight: 357.44
Associated Items:
Representations
Canonical SMILES: COc1ccc(-c2ccc3c(N4CCOCC4)snc3n2)cc1OC
Standard InChI: InChI=1S/C18H19N3O3S/c1-22-15-6-3-12(11-16(15)23-2)14-5-4-13-17(19-14)20-25-18(13)21-7-9-24-10-8-21/h3-6,11H,7-10H2,1-2H3
Standard InChI Key: WTTBURFWFGLEBN-UHFFFAOYSA-N
Associated Targets(Human)
Serine/threonine-protein kinase GAK 1150 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 357.44 | Molecular Weight (Monoisotopic): 357.1147 | AlogP: 3.21 | #Rotatable Bonds: 4 |
| Polar Surface Area: 56.71 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 0.69 | CX LogP: 3.20 | CX LogD: 3.20 |
| Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.71 | Np Likeness Score: -1.10 |
References
| 1. Callis TB, Garrett TR, Montgomery AP, Danon JJ, Kassiou M.. (2022) Recent Scaffold Hopping Applications in Central Nervous System Drug Discovery., 65 (20.0): [PMID:36206553] [10.1021/acs.jmedchem.2c00969] |
Source
Source(1):